Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence

Overview of attention for article published in Annals of Surgical Oncology, September 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 8 news stories from 8 outlets.

Publication comes ahead of the FDA Advisory Panel Meeting for Marketing Authorization of ProSense® in Early-Stage Low Risk…

PR Newswire CAESAREA, Israel, Sept. 24, 2024 Publication comes ahead of the FDA Advisory Panel Meeting for Marketing…

Publication comes ahead of the FDA Advisory Panel Meeting for Marketing Authorization of ProSense® in Early-Stage Low Risk…

Publication comes ahead of the FDA Advisory Panel Meeting for Marketing Authorization of ProSense® in Early-Stage Low Risk…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 4 additional news stories.